Predictions
Valneva SE
Start price
Target price
Perf. (%)
€10.89
17.06.21
17.06.21
€8.00
17.06.22
17.06.22
3.21%
20.07.21
20.07.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€20.60
17.06.21
17.06.21
€17.00
17.06.22
17.06.22
38.84%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€73.80
17.06.21
17.06.21
€50.00
17.06.22
17.06.22
-66.50%
17.08.21
17.08.21
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€46.95
16.06.21
16.06.21
€75.00
16.06.22
16.06.22
2.24%
28.06.21
28.06.21
Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
Novartis AG ADR
Start price
Target price
Perf. (%)
€77.60
15.06.21
15.06.21
-
15.06.24
15.06.24
19.07%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€13.20
14.06.21
14.06.21
€24.00
14.06.22
14.06.22
0.00%
26.06.21
26.06.21
Could be worthwhile Investment >10% per year
Good culture
Little innovation
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€19.30
14.06.21
14.06.21
€22.00
14.06.22
14.06.22
6.74%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
CytRx Corp.
Start price
Target price
Perf. (%)
€2.50
13.06.21
13.06.21
-
13.06.22
13.06.22
-66.00%
27.06.21
27.06.21
Risky Investment
CytRx Corp.
Start price
Target price
Perf. (%)
€2.50
12.06.21
12.06.21
-
12.06.22
12.06.22
-95.75%
13.06.22
13.06.22
Could be worthwhile Investment >10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€10.12
12.06.21
12.06.21
€25.00
12.06.22
12.06.22
-70.64%
13.06.22
13.06.22
Could be very worthwhile Investment >20% year
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€18.77
11.06.21
11.06.21
€23.20
11.06.22
11.06.22
-14.32%
24.06.21
24.06.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Galapagos N.V.
Start price
Target price
Perf. (%)
€65.08
09.06.21
09.06.21
€70.00
09.06.22
09.06.22
-30.73%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year
Invitae Corp
Start price
Target price
Perf. (%)
€25.10
09.06.21
09.06.21
€30.00
09.06.22
09.06.22
-89.88%
10.06.22
10.06.22
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€320.85
08.06.21
08.06.21
€330.00
08.06.22
08.06.22
-41.88%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
AstraZeneca plc
Start price
Target price
Perf. (%)
€91.61
03.06.21
03.06.21
€115.00
03.06.22
03.06.22
34.21%
04.06.22
04.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Haemato AG
Start price
Target price
Perf. (%)
€29.20
31.05.21
31.05.21
-
31.05.24
31.05.24
-36.99%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.74
31.05.21
31.05.21
€15.00
31.05.22
31.05.22
-60.61%
01.06.22
01.06.22
Fair valuation
Strong uniques
Leading role in innovation
Bad rating
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.18
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
4.59%
14.06.21
14.06.21
Could be worthwhile Investment >10% per year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.44
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
-2.46%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year